Abstract
Aims
This study aimed to investigate the risk factors and prognostic value of anxiety and depression in glioma patients.
Methods
A total of 190 glioma patients who underwent resection were consecutively enrolled. Anxiety was assessed using hospital anxiety and depression scale (HADS) and Zung self-rating anxiety scale (SAS); depression was assessed with the use of HADS and Zung self-rating depression scale (SDS). All patients were followed up to death or 36 months. Overall survival (OS) was calculated according to the survival data.
Results
The prevalence of anxiety ranged from 36.3 to 37.4%, and the prevalence of depression ranged from 28.4 to 32.6% based on different assessment scales. Female, diabetes, and increased WHO grade were correlated with HADS anxiety and SAS anxiety, while female, single/divorced/widowed status, hyperlipidemia, diabetes, and CKD were associated with HADS depression and SDS depression. Further multivariate logistic analyses disclosed the following: single/divorced/widowed status and WHO grade were independent risk factors for HADS anxiety; female and hyperlipidemia were independent risk factors for SAS anxiety; whereas education duration (< 12 years), single/divorced/widowed status, and CKD were independent risk factors for HADS depression; female, single/divorced/widowed status, and hyperlipidemia were independent risk factors for SDS depression. Besides, HADS anxiety, SAS anxiety and SDS depression were correlated with shorter OS, while HADS depression was not.
Conclusions
Our findings about the risk factors and prognostic value of anxiety and depression might aid for their early prevention and prognosis improvement in glioma patients.
Similar content being viewed by others
References
Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820. https://doi.org/10.1007/s00401-016-1545-1
Ostrom QT, Gittleman H, Fulop J et al (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro Oncol 17(Suppl 4):iv1–iv62. https://doi.org/10.1093/neuonc/nov189
Rooney AG, Carson A, Grant R (2011) Depression in cerebral glioma patients: a systematic review of observational studies. J Natl Cancer Inst 103(1):61–76. https://doi.org/10.1093/jnci/djq458
Jiao JT, Jiang C, Huang J et al (2014) Metabolic syndrome factors and risk of postoperative depression in high-grade glioma patients in a 1.5-year prospective study. Med Oncol 31(10):234. https://doi.org/10.1007/s12032-014-0234-y
Ader R, Cohen N, Felten D (1995) Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet 345(8942):99–103. https://doi.org/10.1016/s0140-6736(95)90066-7
Yirmiya R (2000) Depression in medical illness: the role of the immune system. West J Med 173(5):333–336. https://doi.org/10.1136/ewjm.173.5.333
Mainio A, Hakko H, Niemela A et al (2003) The effect of brain tumour laterality on anxiety levels among neurosurgical patients. J Neurol Neurosurg Psychiatry 74(9):1278–1282. https://doi.org/10.1136/jnnp.74.9.1278
Kilbride L, Smith G, Grant R (2007) The frequency and cause of anxiety and depression amongst patients with malignant brain tumours between surgery and radiotherapy. J Neurooncol 84(3):297–304. https://doi.org/10.1007/s11060-007-9374-7
Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109. https://doi.org/10.1007/s00401-007-0243-4
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370
Gainotti G, Cianchetti C, Taramelli M, Tiacci C (1972) The guided self-rating anxiety-depression scale for use in clinical psychopharmacology. Act Nerv Super (Praha) 14(1):49–51
Zung WW, Gianturco JA (1971) Personality dimension and the Self-Rating Depression Scale. J Clin Psychol 27(2):247–248. https://doi.org/10.1002/1097-4679(197104)27:2<247::aid-jclp2270270230>3.0.co;2-6
Rogers L, Barani I, Chamberlain M et al (2015) Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg 122(1):4–23. https://doi.org/10.3171/2014.7.JNS131644
Pranckeviciene A, Bunevicius A (2015) Depression screening in patients with brain tumors: a review. CNS Oncol 4(2):71–78. https://doi.org/10.2217/cns.14.60
Pringle AM, Taylor R, Whittle IR (1999) Anxiety and depression in patients with an intracranial neoplasm before and after tumour surgery. Br J Neurosurg 13(1):46–51. https://doi.org/10.1080/02688699944177
van der Vossen S, Schepers VP, Berkelbach van der Sprenkel JW et al (2014) Cognitive and emotional problems in patients after cerebral meningioma surgery. J Rehabil Med 46(5):430–437. https://doi.org/10.2340/16501977-1795
D'Angelo C, Mirijello A, Leggio L et al (2008) State and trait anxiety and depression in patients with primary brain tumors before and after surgery: 1-year longitudinal study. J Neurosurg 108(2):281–286. https://doi.org/10.3171/JNS/2008/108/2/0281
Bunevicius A, Deltuva VP, Tamasauskas A (2017) Association of pre-operative depressive and anxiety symptoms with five-year survival of glioma and meningioma patients: a prospective cohort study. Oncotarget 8(34):57543–57551. https://doi.org/10.18632/oncotarget.15743
Wang Y, Huang M, Jiao JT et al (2014) Relationship between concentrations of IGF-1 and IGFBP-3 and preoperative depression risk, and effect of psychological intervention on outcomes of high-grade glioma patients with preoperative depression in a 2-year prospective study. Med Oncol 31(5):921. https://doi.org/10.1007/s12032-014-0921-8
Bektas DK, Demir S (2016) Anxiety, depression levels and quality of life in patients with gastrointestinal cancer in Turkey. Asian Pac J Cancer Prev 17(2):723–731. https://doi.org/10.7314/apjcp.2016.17.2.723
Villar RR, Fernandez SP, Garea CC et al (2017) Quality of life and anxiety in women with breast cancer before and after treatment. Rev Lat Am Enfermagem 25:e2958. https://doi.org/10.1590/1518-8345.2258.2958
Tietge UJ (2014) Hyperlipidemia and cardiovascular disease: inflammation, dyslipidemia, and atherosclerosis. Curr Opin Lipidol 25(1):94–95. https://doi.org/10.1097/MOL.0000000000000051
Alexopoulos GS, Meyers BS, Young RC et al (1997) ‘Vascular depression’ hypothesis. Arch Gen Psychiatry 54(10):915–922. https://doi.org/10.1001/archpsyc.1997.01830220033006
Ekramzadeh M, Mazloom Z, Sagheb M (2015) Association of depression with selenium deficiency and nutritional markers in the patients with end-stage renal disease on hemodialysis. J Ren Nutr 25(4):381–387. https://doi.org/10.1053/j.jrn.2014.12.005
Litofsky NS, Farace E, Anderson F Jr et al (2004) Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurgery 54(2):358–366; discussion 366–357. https://doi.org/10.1227/01.neu.0000103450.94724.a2
Gathinji M, McGirt MJ, Attenello FJ et al (2009) Association of preoperative depression and survival after resection of malignant brain astrocytoma. Surg Neurol 71(3):299–303, discussion 303. https://doi.org/10.1016/j.surneu.2008.07.016
Mainio A, Hakko H, Timonen M et al (2005) Depression in relation to survival among neurosurgical patients with a primary brain tumor: a 5-year follow-up study. Neurosurgery 56(6):1234–1241; discussion 1241–1232. https://doi.org/10.1227/01.neu.0000159648.44507.7f
Shi C, Lamba N, Zheng LJ et al (2018) Depression and survival of glioma patients: a systematic review and meta-analysis. Clin Neurol Neurosurg 172:8–19. https://doi.org/10.1016/j.clineuro.2018.06.016